Search Count: 72
 |
Crystal Structure Of Htlv-1 Protease Bound To Darunavir At 2.1 Angstroms With Truncated Flaps
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-01-21 Classification: VIRAL PROTEIN/INHIBITOR Ligands: PG4, 017, DMS, PO4 |
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION
Release Date: 2026-01-21
Ligands: PG4, 017, DMS, PO4
 |
X-Ray Crystal Structure Of Multi-Drug Resistant Hiv-1 Protease (P51) In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2024-08-07 Classification: VIRAL PROTEIN Ligands: 017, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2024-08-07
Ligands: 017, GOL
 |
The Hiv Protease Inhibitor Darunavir Binding To The Active Site Of Cryphonectria Parasitica Endothiapepsin
Organism: Cryphonectria parasitica
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2024-07-24 Classification: HYDROLASE Ligands: 017, DMS, NA, EDO |
Organism: Cryphonectria parasitica
Method: X-RAY DIFFRACTION
Release Date: 2024-07-24
Ligands: 017, DMS, NA, EDO
 |
Drug Resistant Hiv-1 Protease (L10I, V32I, L33F, K45I, M46I, I50V, A71V, V82I, I84V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 017
 |
Drug Resistant Hiv-1 Protease (L10F, V32I, L33F, K45I, A71V, V82I, I84V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017, SO4 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 017, SO4
 |
Drug Resistant Hiv-1 Protease (L10F, M46I, I47V, I50V, F53L, L63P, I72V, G73S, V82I, I85V) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 017
 |
Drug Resistant Hiv-1 Protease (L10F, M46I, I50V, F53L, L63P, G73S) In Complex With Drv
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2022-11-09 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2022-11-09
Ligands: 017
 |
Porcine Pepsin In Complex With Darunavir
Organism: Sus scrofa
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-06-16 Classification: HYDROLASE/INHIBITOR Ligands: 017 |
Organism: Sus scrofa
Method: X-RAY DIFFRACTION
Release Date: 2021-06-16
Ligands: 017
 |
Wt Htlv-1 Protease In Complex With Darunavir (Drv)
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2021-03-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human t-cell leukemia virus type i
Method: X-RAY DIFFRACTION
Release Date: 2021-03-17
Ligands: 017
 |
Hiv-1 Protease Multiple Mutant Prs5B With Darunavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2020-04-15 Classification: Hydrolase/Hydrolase Inhibitor, Viral Protein Ligands: PO4, 017 |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-15
Ligands: PO4, 017
 |
Hiv-1 Protease Nl4-3 Wt In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017, SO4
 |
Hiv-1 Protease Nl4-3 K45I, M46I, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 I13V, G16E, V32I, L33F, K45I, M46I, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: SO4, 017
 |
Hiv-1 Protease Nl4-3 I13V, G16E, V32I, L33F, K45I, M46I, L76V, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2019-09-04 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-09-04
Ligands: 017
 |
Hiv-1 Protease Nl4-3 L90M Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2019-08-21 Classification: hydrolase/hydrolase inhibitor Ligands: SO4, 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-08-21
Ligands: SO4, 017
 |
Hiv-1 Protease Nl4-3 L89V, L90M Mutant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2019-08-21 Classification: hydrolase/hydrolase inhibitor Ligands: SO4, 017 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-08-21
Ligands: SO4, 017